Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Clinical trial NCT00240643 · COMPLETED

Trial details

NCT number: NCT00240643
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrillation, Atrial Atrial Fibrillation

Start date: 2005-11-01
Primary completion: 2006-12-01
Enrollment: 640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.